MB Farmakoekonomikos institutas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 223,500 |
| - |
| 144,722 |
| 135,906 |
| - |
| 100.00 |
| 60.81 |
| 137,401 |
| 15,112 |
| 0 |
| 152,513 |
| 2024 |
|---|
| 234,600 |
| - |
| 158,809 |
| 149,556 |
| - |
| 100.00 |
| 63.75 |
| 151,051 |
| 23,763 |
| 0 |
| 174,814 |
| 2025 |
|---|
| 142,000 |
| - |
| 70,493 |
| 65,012 |
| - |
| 100.00 |
| 45.78 |
| 116,063 |
| 16,131 |
| 0 |
| 132,194 |
Register and
explore Okredo data| 2025 |
|---|
| 142,000 |
| - |
| 70,493 |
| 65,012 |
| - |
| 100.00 |
| 45.78 |
| 116,063 |
| 16,131 |
| 0 |
| 132,194 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
142,000 €-39 % *
Sales per employee (€)
-Profit before tax (€)
70,493 €-56 % *
Net Profit (€)
65,012 €-57 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
45.78 %-28.19 % *
Equity (€)
116,063 €-23 % *
Amounts Payable And Liabilities (€)
16,131 €-32 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
132,194 €-24 % *
